Rudloff M, Zumbo P, Favret N, Roetman J, Detres Roman C, Erwin M
Nat Immunol. 2023; 24(9):1527-1539.
PMID: 37537361
PMC: 10878719.
DOI: 10.1038/s41590-023-01578-y.
Lindsay R, Melssen M, Stasiak K, Annis J, Woods A, Rodriguez A
Front Oncol. 2022; 12:1058894.
PMID: 36531040
PMC: 9755581.
DOI: 10.3389/fonc.2022.1058894.
Zhylko A, Winiarska M, Graczyk-Jarzynka A
Cancers (Basel). 2020; 12(8).
PMID: 32722109
PMC: 7466082.
DOI: 10.3390/cancers12082030.
Sillito F, Holler A, Stauss H
Cells. 2020; 9(7).
PMID: 32708397
PMC: 7407306.
DOI: 10.3390/cells9071721.
Lindner S, Johnson S, Brown C, Wang L
Sci Adv. 2020; 6(21):eaaz3223.
PMID: 32637585
PMC: 7314561.
DOI: 10.1126/sciadv.aaz3223.
Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence.
Judge S, Murphy W, Canter R
Front Cell Infect Microbiol. 2020; 10:49.
PMID: 32117816
PMC: 7031155.
DOI: 10.3389/fcimb.2020.00049.
Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones.
Grossman M, Hofmann C, Ng H, Yang O
AIDS. 2019; 33(10):1565-1574.
PMID: 31306165
PMC: 7046083.
DOI: 10.1097/QAD.0000000000002259.
T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.
Woodham A, Yan L, Skeate J, van der Veen D, Brand H, Wong M
Papillomavirus Res. 2016; 2:21-30.
PMID: 27182559
PMC: 4862606.
DOI: 10.1016/j.pvr.2016.01.002.
T cell-specific notch inhibition blocks graft-versus-host disease by inducing a hyporesponsive program in alloreactive CD4+ and CD8+ T cells.
Sandy A, Chung J, Toubai T, Shan G, Tran I, Friedman A
J Immunol. 2013; 190(11):5818-28.
PMID: 23636056
PMC: 3660433.
DOI: 10.4049/jimmunol.1203452.
Program death-1 regulates peripheral T cell tolerance via an anergy-independent mechanism.
Qiao G, Yang L, Li Z, Ying H, Hassen Y, Yin F
Clin Immunol. 2012; 143(2):128-33.
PMID: 22459706
PMC: 3327760.
DOI: 10.1016/j.clim.2012.02.006.
Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells.
Engelhardt J, Boldajipour B, Beemiller P, Pandurangi P, Sorensen C, Werb Z
Cancer Cell. 2012; 21(3):402-17.
PMID: 22439936
PMC: 3311997.
DOI: 10.1016/j.ccr.2012.01.008.
Once a killer, always a killer: from cytotoxic T cell to memory cell.
Lefrancois L, Obar J
Immunol Rev. 2010; 235(1):206-18.
PMID: 20536565
PMC: 2989239.
DOI: 10.1111/j.0105-2896.2010.00895.x.
Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.
English K, Ryan J, Tobin L, Murphy M, Barry F, Mahon B
Clin Exp Immunol. 2009; 156(1):149-60.
PMID: 19210524
PMC: 2673753.
DOI: 10.1111/j.1365-2249.2009.03874.x.
Protein kinase Cdelta regulates antigen receptor-induced lytic granule polarization in mouse CD8+ CTL.
Ma J, Monu N, Shen D, Mecklenbrauker I, Radoja N, Haydar T
J Immunol. 2007; 178(12):7814-21.
PMID: 17548619
PMC: 3712856.
DOI: 10.4049/jimmunol.178.12.7814.
A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell function.
Bendle G, Xue S, Holler A, Stauss H
PLoS One. 2007; 2(4):e353.
PMID: 17406677
PMC: 1831496.
DOI: 10.1371/journal.pone.0000353.
Molecular mechanisms for adaptive tolerance and other T cell anergy models.
Choi S, Schwartz R
Semin Immunol. 2007; 19(3):140-52.
PMID: 17400472
PMC: 2045643.
DOI: 10.1016/j.smim.2007.02.005.
Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation.
Mescher M, Agarwal P, Casey K, Hammerbeck C, Xiao Z, Curtsinger J
Semin Immunol. 2007; 19(3):153-61.
PMID: 17382557
PMC: 1955740.
DOI: 10.1016/j.smim.2007.02.007.
Immunosuppressive strategies that are mediated by tumor cells.
Rabinovich G, Gabrilovich D, Sotomayor E
Annu Rev Immunol. 2006; 25:267-96.
PMID: 17134371
PMC: 2895922.
DOI: 10.1146/annurev.immunol.25.022106.141609.
Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.
Mallone R, Nepom G
Am J Ther. 2005; 12(6):534-50.
PMID: 16280647
PMC: 2760127.
DOI: 10.1097/01.mjt.0000178772.54396.38.
Mesenchymal stem cells avoid allogeneic rejection.
Ryan J, Barry F, Murphy J, Mahon B
J Inflamm (Lond). 2005; 2:8.
PMID: 16045800
PMC: 1215510.
DOI: 10.1186/1476-9255-2-8.